文献速递类风湿关节炎

I型干扰素激活经典单核细胞与GZMK+CD8+T细胞标志超声阴性期即将发生的类风湿关节炎

Type I interferon activation in classical monocytes and GZMK+ CD8+ T cells characterises the ultrasound-negative phase of imminent rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2026-10-22

该研究对22例ACPA阳性即将进展为RA的高危个体(按超声亚临床滑膜炎有无分层)及18例ACPA阳性非进展者进行单细胞RNA测序和蛋白质组分析,发现超声阴性进展者外周CD14+经典单核细胞和GZMK+CD8+T细胞中I型干扰素上调,而超声阳性进展者则转向IL1β+单核细胞和GZMB+CD8+T细胞克隆扩增。

要点

  • ACPA阳性高危个体在超声亚临床滑膜炎出现前已存在I型干扰素驱动的单核细胞和GZMK+CD8+T细胞激活。
  • 超声阳性进展者表现为CD14+经典单核细胞向IL1β+表型偏移及GZMB+CD8+T细胞克隆扩增。
  • GZMB+与GZMK+CD8+T细胞克隆型基本不同,提示不同炎症程序与滑膜炎发生相关。

核心结论

  • ACPA阳性高危个体中,I型干扰素驱动的外周固有CD14+经典单核细胞和GZMK+CD8+T细胞亚群激活发生于亚临床滑膜炎出现之前、RA即将发生时。
  • 包括GZMB+CD8+T细胞克隆扩增在内的独特炎症和效应程序与亚临床滑膜炎的发生相关。

研究设计与样本

  • 对前瞻性收集的高危ACPA阳性即将进展者(n=22)和ACPA阳性非进展者(n=18)的血样进行单细胞RNA测序和蛋白质组分析。
  • 即将进展者进一步按超声可检测的亚临床滑膜炎有无分层:超声阴性进展者n=11,超声阳性进展者n=11。

主要发现

  • 超声阴性(USneg,n=11)即将进展者外周CD14+经典单核细胞和GZMK+CD8+T细胞中I型干扰素上调。
  • 超声阳性(USpos,n=11)进展者CD14+经典单核细胞向IL1β+表达表型偏移,并出现GZMB+细胞毒性CD8+T细胞克隆扩增。
  • GZMB+与GZMK+CD8+T细胞克隆型基本不同。
  • 血浆蛋白质组显示超声阴性进展者以Toll样受体相关固有通路为主,超声阳性进展者转向效应和组织重塑特征。

临床怎么用

  • 对于ACPA阳性高危个体,I型干扰素相关单核细胞和GZMK+CD8+T细胞激活可能有助于识别超声阴性但即将进展为RA的阶段。
  • GZMB+CD8+T细胞克隆扩增和IL1β+单核细胞偏移可能与亚临床滑膜炎出现相关,可作为进一步分层监测的候选标志。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rheumatoid arthritis (RA) is a prototypical autoimmune disease, characterised by prolonged systemic autoimmunity before organ-specific tissue inflammation. Understanding immune mechanisms that drive the transition from systemic autoimmunity to joint-specific pathology is key to arthritis prevention. In this study, we define immune signatures in anticitrullinated protein antibodies-positive (ACPA+) at-risk individuals who imminently progress to RA, comparing those with and without ultrasound (US)-detectable subclinical synovitis. METHODS: We performed single‑cell RNA sequencing and proteomic profiling on prospectively collected blood samples from high-risk ACPA+ imminent progressors (n = 22), who were further stratified by the presence or absence of US-detectable subclinical synovitis and compared them with ACPA+ nonprogressors (n=18). RESULTS: We found type I interferon (IFN-I) upregulation in peripheral CD14+ classical monocyte and Granzyme K protein (GZMK)+ CD8+ T cells in US-negative (USneg, n = 11) imminent progressors. In contrast, US-positive (USpos, n = 11) progressors exhibited a phenotypic shift in CD14+ classical monocytes towards interleukin 1 beta (IL1ß)+ expression and clonal expansion of GZMB+ cytotoxic CD8+ T cells. GZMB+ and GZMK+ CD8+ T cells were largely clonotypically distinct. Plasma proteomics also revealed a shift from Toll-like receptor-associated innate pathways in USneg progressors towards effector and tissue-remodelling signatures in USpos progressors. CONCLUSIONS: In ACPA+ high-risk individuals, IFN-I-driven activation of peripheral innate CD14+ classical monocytes and GZMK+ CD8+ T cell subsets occur before the onset of subclinical synovitis when RA is imminent. Distinct inflammatory and effector programmes, including GZMB+ CD8+ T cells clonal expansion, are associated with the onset of subclinical synovitis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tariq F, Martin P, Abacar K, et al. Type I interferon activation in classical monocytes and GZMK+ CD8+ T cells characterises the ultrasound-negative phase of imminent rheumatoid arthritis. Ann Rheum Dis. 2026. PMID: 42918701. doi:10.1016/j.ard.2026.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。